Thyroid uptake scan gamma probe

Product Overview
Designed for quantitative measurement and mapping of Iodine-131 activity in patients undergoing radionuclide therapy, this system combines a high-resolution linear array imaging detector and a NaI scintillation detector to provide whole-body and organ-level dose assessment for clinical departments.

Key Features

• Imaging detector: linear array scanning, 0.4 mm resolution; selectable grayscale or color display.
• NaI detector: 2-inch crystal volume; energy resolution < 7%.
• Real-time nuclide identification including I-131, F-18, Tc-99 and other commonly used radionuclides.
• Measurement range: 5–400 mCi (185 MBq–14800 MBq).
• Measurement accuracy: < 3000 Bq.
• Automatic height and weight measurement using top ultrasonic and bottom sensors for patient positioning.

Applications

• Radiology Department: Imaging and quantitative assessment of radionuclide distribution for diagnostic follow-up.
• Radiation Oncology: Dose monitoring and whole-body mapping for patients treated with therapeutic radioisotopes.
• Nuclear Medicine: Integrated imaging and dosimetry for diagnostic and therapeutic workflows.

Technical specifications

• Dimensions: 60 cm x 40 cm x 190 cm.
• Power supply: AC 220 V compatible.
• Data processing: queryable data output, report generation, external system interfaces and hospital reporting integration.
• Report outputs: whole-body dose distribution map; predicted trends of residual activity in organs.

Keywords
Iodine-131 measurement system